Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker forBreast Cancer

Abstract

Finally, siRNA-mediated AIMP2 knockdown inhibited BRCA cell proliferation and migration <i>in vitro</i>. In conclusion, our pan-cancer analysis suggests that AIMP2 may play a crucial role in tumor immunity and could serve as a potential prognostic marker, particularly in BRCA.